Annual EBIT
$1.62 B
-$170.90 M-9.57%
31 December 2023
Summary:
Edwards Lifesciences annual earnings before interest & taxes is currently $1.62 billion, with the most recent change of -$170.90 million (-9.57%) on 31 December 2023. During the last 3 years, it has fallen by -$104.70 million (-6.09%). EW annual EBIT is now -9.57% below its all-time high of $1.93 billion.EW EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$394.30 M
+$17.10 M+4.53%
30 September 2024
Summary:
Edwards Lifesciences quarterly earnings before interest & taxes is currently $394.30 million, with the most recent change of +$17.10 million (+4.53%) on 30 September 2024. Over the past year, it has increased by +$80.00 million (+25.45%). EW quarterly EBIT is now -51.85% below its all-time high of $818.90 million, reached on 31 December 2014.EW Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$1.52 B
-$26.30 M-1.70%
30 September 2024
Summary:
Edwards Lifesciences TTM earnings before interest & taxes is currently $1.52 billion, with the most recent change of -$26.30 million (-1.70%) on 30 September 2024. Over the past year, it has dropped by -$28.50 million (-1.84%). EW TTM EBIT is now -17.16% below its all-time high of $1.84 billion, reached on 30 September 2022.EW TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EW EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +25.4% | -1.8% |
| 3 y3 years | -6.1% | -20.7% | -11.4% |
| 5 y5 years | +36.1% | +33.5% | +28.3% |
EW EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -9.6% | +73.3% | -20.7% | +25.4% | -17.2% | +26.9% |
| 5 y | 5 years | -9.6% | +104.2% | -20.7% | +1821.8% | -17.2% | +68.8% |
| alltime | all time | -9.6% | +6604.1% | -51.9% | +839.8% | -17.2% | +6221.6% |
Edwards Lifesciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $394.30 M(+4.5%) | $1.52 B(-1.7%) |
| June 2024 | - | $377.20 M(-13.8%) | $1.55 B(-0.5%) |
| Mar 2024 | - | $437.70 M(+39.3%) | $1.56 B(+0.3%) |
| Dec 2023 | $1.62 B(-9.6%) | $314.30 M(-25.3%) | $1.55 B(-7.7%) |
| Sept 2023 | - | $420.60 M(+9.4%) | $1.68 B(-2.0%) |
| June 2023 | - | $384.50 M(-11.1%) | $1.72 B(-3.4%) |
| Mar 2023 | - | $432.60 M(-2.7%) | $1.78 B(-0.6%) |
| Dec 2022 | $1.79 B(+3.8%) | $444.60 M(-2.1%) | $1.79 B(-2.8%) |
| Sept 2022 | - | $454.30 M(+2.2%) | $1.84 B(+3.3%) |
| June 2022 | - | $444.70 M(+0.4%) | $1.78 B(+0.2%) |
| Mar 2022 | - | $443.00 M(-10.9%) | $1.78 B(+3.3%) |
| Dec 2021 | $1.72 B(+84.5%) | $497.00 M(+25.5%) | $1.72 B(+43.3%) |
| Sept 2021 | - | $396.10 M(-10.4%) | $1.20 B(+3.3%) |
| June 2021 | - | $441.90 M(+14.7%) | $1.16 B(+22.3%) |
| Mar 2021 | - | $385.40 M(-1783.0%) | $949.50 M(+1.8%) |
| Dec 2020 | $932.50 M(-21.5%) | -$22.90 M(-106.4%) | $932.50 M(-25.4%) |
| Sept 2020 | - | $357.20 M(+55.4%) | $1.25 B(+4.8%) |
| June 2020 | - | $229.80 M(-37.6%) | $1.19 B(-4.2%) |
| Mar 2020 | - | $368.40 M(+24.8%) | $1.25 B(+5.0%) |
| Dec 2019 | $1.19 B(+50.0%) | $295.30 M(-1.5%) | $1.19 B(+31.6%) |
| Sept 2019 | - | $299.90 M(+6.2%) | $902.30 M(+5.8%) |
| June 2019 | - | $282.50 M(-8.7%) | $852.80 M(+1.7%) |
| Mar 2019 | - | $309.50 M(+2876.0%) | $838.80 M(+6.0%) |
| Dec 2018 | $791.30 M(-25.2%) | $10.40 M(-95.8%) | $791.30 M(-25.1%) |
| Sept 2018 | - | $250.40 M(-6.7%) | $1.06 B(+2.9%) |
| June 2018 | - | $268.50 M(+2.5%) | $1.03 B(+1.7%) |
| Mar 2018 | - | $262.00 M(-5.1%) | $1.01 B(-4.5%) |
| Dec 2017 | $1.06 B(+39.8%) | $276.00 M(+25.1%) | $1.06 B(+10.2%) |
| Sept 2017 | - | $220.70 M(-12.4%) | $960.30 M(+2.7%) |
| June 2017 | - | $251.80 M(-18.7%) | $935.00 M(+8.2%) |
| Mar 2017 | - | $309.60 M(+73.7%) | $864.20 M(+14.1%) |
| Dec 2016 | $757.10 M(+18.4%) | $178.20 M(-8.8%) | $757.10 M(+0.9%) |
| Sept 2016 | - | $195.40 M(+8.0%) | $750.50 M(+5.6%) |
| June 2016 | - | $181.00 M(-10.6%) | $710.90 M(+5.1%) |
| Mar 2016 | - | $202.50 M(+18.0%) | $676.70 M(+5.8%) |
| Dec 2015 | $639.60 M(-44.9%) | $171.60 M(+10.1%) | $639.60 M(-50.3%) |
| Sept 2015 | - | $155.80 M(+6.1%) | $1.29 B(+2.1%) |
| June 2015 | - | $146.80 M(-11.2%) | $1.26 B(+2.2%) |
| Mar 2015 | - | $165.40 M(-79.8%) | $1.23 B(+6.2%) |
| Dec 2014 | $1.16 B(+122.9%) | $818.90 M(+532.4%) | $1.16 B(+124.3%) |
| Sept 2014 | - | $129.50 M(+8.5%) | $517.80 M(+4.9%) |
| June 2014 | - | $119.30 M(+27.6%) | $493.80 M(-1.4%) |
| Mar 2014 | - | $93.50 M(-46.7%) | $501.00 M(-3.8%) |
| Dec 2013 | $521.00 M(+32.7%) | $175.50 M(+66.4%) | $521.00 M(+11.8%) |
| Sept 2013 | - | $105.50 M(-16.6%) | $466.00 M(+2.5%) |
| June 2013 | - | $126.50 M(+11.5%) | $454.80 M(+8.4%) |
| Mar 2013 | - | $113.50 M(-5.8%) | $419.40 M(+7.0%) |
| Dec 2012 | $392.60 M | $120.50 M(+27.8%) | $392.00 M(+15.0%) |
| Sept 2012 | - | $94.30 M(+3.5%) | $341.00 M(+11.7%) |
| June 2012 | - | $91.10 M(+5.8%) | $305.30 M(+6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $86.10 M(+23.9%) | $287.70 M(+0.3%) |
| Dec 2011 | $286.70 M(+5.9%) | $69.50 M(+18.6%) | $286.70 M(-0.4%) |
| Sept 2011 | - | $58.60 M(-20.3%) | $287.80 M(-2.8%) |
| June 2011 | - | $73.50 M(-13.6%) | $296.10 M(+2.2%) |
| Mar 2011 | - | $85.10 M(+20.5%) | $289.70 M(+7.1%) |
| Dec 2010 | $270.60 M(-11.9%) | $70.60 M(+5.5%) | $270.40 M(+2.9%) |
| Sept 2010 | - | $66.90 M(-0.3%) | $262.70 M(-9.7%) |
| June 2010 | - | $67.10 M(+2.0%) | $290.90 M(+1.3%) |
| Mar 2010 | - | $65.80 M(+4.6%) | $287.10 M(-6.5%) |
| Dec 2009 | $307.10 M(+79.0%) | $62.90 M(-33.9%) | $307.10 M(+12.7%) |
| Sept 2009 | - | $95.10 M(+50.2%) | $272.40 M(+22.9%) |
| June 2009 | - | $63.30 M(-26.2%) | $221.60 M(+4.4%) |
| Mar 2009 | - | $85.80 M(+204.3%) | $212.30 M(+30.0%) |
| Dec 2008 | $171.60 M(-0.6%) | $28.20 M(-36.3%) | $163.30 M(-9.5%) |
| Sept 2008 | - | $44.30 M(-18.0%) | $180.50 M(+4.5%) |
| June 2008 | - | $54.00 M(+46.7%) | $172.80 M(+4.2%) |
| Mar 2008 | - | $36.80 M(-18.9%) | $165.90 M(-4.5%) |
| Dec 2007 | $172.60 M(-0.3%) | $45.40 M(+24.0%) | $173.70 M(+1.3%) |
| Sept 2007 | - | $36.60 M(-22.3%) | $171.40 M(-2.1%) |
| June 2007 | - | $47.10 M(+5.6%) | $175.00 M(+0.8%) |
| Mar 2007 | - | $44.60 M(+3.5%) | $173.60 M(-11.0%) |
| Dec 2006 | $173.20 M(-1.2%) | $43.10 M(+7.2%) | $195.00 M(-1.9%) |
| Sept 2006 | - | $40.20 M(-12.0%) | $198.80 M(+0.1%) |
| June 2006 | - | $45.70 M(-30.8%) | $198.70 M(-0.2%) |
| Mar 2006 | - | $66.00 M(+40.7%) | $199.00 M(+13.3%) |
| Dec 2005 | $175.30 M(+13.5%) | $46.90 M(+17.0%) | $175.60 M(+4.2%) |
| Sept 2005 | - | $40.10 M(-12.8%) | $168.50 M(+2.9%) |
| June 2005 | - | $46.00 M(+8.0%) | $163.70 M(+3.5%) |
| Mar 2005 | - | $42.60 M(+7.0%) | $158.20 M(+13.8%) |
| Dec 2004 | $154.40 M(+11.6%) | $39.80 M(+12.7%) | $139.00 M(+0.5%) |
| Sept 2004 | - | $35.30 M(-12.8%) | $138.30 M(+2.5%) |
| June 2004 | - | $40.50 M(+73.1%) | $134.90 M(+7.5%) |
| Mar 2004 | - | $23.40 M(-40.2%) | $125.50 M(-7.1%) |
| Dec 2003 | $138.40 M(+165.6%) | $39.10 M(+22.6%) | $135.10 M(+6.4%) |
| Sept 2003 | - | $31.90 M(+2.6%) | $127.00 M(+134.3%) |
| June 2003 | - | $31.10 M(-5.8%) | $54.20 M(0.0%) |
| Mar 2003 | - | $33.00 M(+6.5%) | $54.20 M(+4.0%) |
| Dec 2002 | $52.10 M(+116.2%) | $31.00 M(-175.8%) | $52.10 M(+8.1%) |
| Sept 2002 | - | -$40.90 M(-231.5%) | $48.20 M(-57.1%) |
| June 2002 | - | $31.10 M(+0.6%) | $112.40 M(+301.4%) |
| Mar 2002 | - | $30.90 M(+14.0%) | $28.00 M(+16.2%) |
| Dec 2001 | $24.10 M(-74.6%) | $27.10 M(+16.3%) | $24.10 M(-44.0%) |
| Sept 2001 | - | $23.30 M(-143.7%) | $43.00 M(-2.3%) |
| June 2001 | - | -$53.30 M(-297.4%) | $44.00 M(-58.2%) |
| Mar 2001 | - | $27.00 M(-41.3%) | $105.30 M(+1.9%) |
| Dec 2000 | $95.00 M(-18.8%) | $46.00 M(+89.3%) | $103.30 M(+80.3%) |
| Sept 2000 | - | $24.30 M(+203.8%) | $57.30 M(+73.6%) |
| June 2000 | - | $8.00 M(-68.0%) | $33.00 M(+32.0%) |
| Mar 2000 | - | $25.00 M | $25.00 M |
| Dec 1999 | $117.00 M | - | - |
FAQ
- What is Edwards Lifesciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly EBIT year-on-year change?
- What is Edwards Lifesciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Edwards Lifesciences?
- What is Edwards Lifesciences TTM EBIT year-on-year change?
What is Edwards Lifesciences annual earnings before interest & taxes?
The current annual EBIT of EW is $1.62 B
What is the all time high annual EBIT for Edwards Lifesciences?
Edwards Lifesciences all-time high annual earnings before interest & taxes is $1.93 B
What is Edwards Lifesciences quarterly earnings before interest & taxes?
The current quarterly EBIT of EW is $394.30 M
What is the all time high quarterly EBIT for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly earnings before interest & taxes is $818.90 M
What is Edwards Lifesciences quarterly EBIT year-on-year change?
Over the past year, EW quarterly earnings before interest & taxes has changed by +$80.00 M (+25.45%)
What is Edwards Lifesciences TTM earnings before interest & taxes?
The current TTM EBIT of EW is $1.52 B
What is the all time high TTM EBIT for Edwards Lifesciences?
Edwards Lifesciences all-time high TTM earnings before interest & taxes is $1.84 B
What is Edwards Lifesciences TTM EBIT year-on-year change?
Over the past year, EW TTM earnings before interest & taxes has changed by -$28.50 M (-1.84%)